Linda Manoogian Fingerle Appointed to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, February 5, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that Linda Manoogian Fingerle was appointed to the Company's Board of Directors. Ms.

Aastrom Biosciences, Inc. Reports Second Quarter Fiscal Year 2004 Financial Results Ann Arbor, Michigan, February 4, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), today reported financial results for the second quarter of fiscal year 2004 ended December 31, 2003.

astrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, February 3, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call tomorrow, Wednesday, February 4, 2004 at 11:00 a.m. EST.

Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, January 30, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call on Wednesday, February 4, 2004 at 11:00 a.m. EST. The call is intended to bring shareholders and

Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, January 30, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call on Wednesday, February 4, 2004 at 11:00 a.m. EST. The call is intended to bring shareholders and

Bergmannsheil University Begins Patient Enrollment for New Stem Cell Treatment of Severe Leg Fractures

-- Bergmannsheil University Begins Patient Enrollment for New Stem Cell Treatment of Severe Leg Fractures --

Evaluation of Stem Cell Product for Leg Fracture Healing Begins in Chicago

-- Evaluation of Stem Cell Product for Leg Fracture Healing Begins in Chicago --

-- Duke Clinical Trial Seeks New Treatment for GI Tract Cancers --